Lymphoma News

Both Hodgkin lymphoma and non-Hodgkin lymphoma, which are cancers of the body's white blood cells, often affect young people who are still in their reproductive years.

New Zealand fashion designers have stepped forward to help Dunedin family Oli Biggs, Amie Richardson, Jasper Biggs and Wayne Biggs.

Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use , the scientific committee of the European Medicines Agency , has adopted a positive opinion on the company's Marketing Authorization Application for ZydeligA , a first-in-class treatment for patients with chronic lymphocytic leukemia and follicular ... (more)

Hospira, the world's leading provider of injectable drugs and infusion technologies, announced today that the results from the ORHEO study have been published in BMC Cancer , and show that the company's European biosimilar epoetin, Retacrit was effective and well tolerated in the management of chemotherapy-induced anemia in patients with solid ... (more)

Have you ever met someone with such enormous talent and a love of life, you just knew they were going big places? For many people in Rosetown, Saskatchewan and across the country that person was musical actor Scott Freethy.

The 45-member SAB reviews grant proposals and makes recommendations regarding research priorities and funding to the Foundation Board of Directors.

As a combination treatment alongside Roche's While the approval also gives Gilead an opportunity in relapsing follicular lymphoma, and small lymphocytic lymphoma as a stand-alone therapy, investors are right to wonder just how big and crowded the market is already.

The event is called 46 Mommas Shave for the Brave. The number is symbolic because statistics say that each weekday 46 moms will find out their child has cancer.

AMSBIO, regular sponsor of the annual Beatson International Cancer Conference announces that the winner of the AMSBIO-Trevigen prize for the best poster was Katarzyna Grzes - a PhD researcher specialising in Cell Signaling and Immunology at the University of Dundee .

And you can say that in spades about Erin Auerbach, a Los Angeles writer who devoted 13 years of her life to providing loving care and, ultimately, extremely expensive medical treatments for three dogs she had adopted from animal shelters.

In the days leading up to my reconstructive surgery, I was scouring breast cancer forums, looking at dozens of reconstruction photos and generally fretting while applying creams and packs to the flat side of my chest.

AS the first notes of Gerry Hunt's drumming solo rose from the speakers, mourners struggled to contain their tears at having lost the gifted musician to cancer.

Editor at Biotech Week -- Research findings on Lymphoproliferative Disorders are discussed in a new report.

Mason Hermes, who was diagnosed with Stage III Burkitts Lymphoma this spring, dressed up for his senior prom on May 3. In a show of support, Hermes' teachers and classmates wore "1 With Mason" T-shirts at St. Anthony Village High School earlier this year.

Today's U.S. Food and Drug Administration approval of idelalisib to treat patients with relapsed chronic lymphocytic leukemia , follicular lymphoma and small lymphocytic lymphoma is a significant advance for patients with these blood cancers.

July 23, 2014 -- The U.S. Food and Drug Administration today approved Zydelig to treat patients with three types of blood cancers.

Dr. James Bianco, president and CEO of CTI BioPharma Corp., said the company is focused on making Pixuvri available to more patients.

The Pennine Panthers from left, are, Ruth Hayes, Fianna Hornby, Belinda McGee, Helen Jones, Joanne Aldred, Kirsty Cookson and Hayley Sherratt FUNDRAISERS across Bury got together to fight cancer by completing the Race for Life at Heaton Park, Prestwich, at the weekend.

The U.S. Food and Drug Administration has approved Gilead Inc's drug Zydelig to treat three types of blood cancer, the agency said on Wednesday.

Hours before Gilead Sciences Inc. is to report what's expected to be record results, the drug developer won Food and Drug Administration approval Wednesday for its first cancer treatment.